CHOSOURCE Trademark

Serial Number: 98524833 • Registration: 7670465

CHOSOURCE is a trademark filed by REVVITY DISCOVERY LIMITED on April 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 40 - Treatment & Processing

Treatment of materials

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

REVVITY DISCOVERY LIMITED (9 trademarks)

8100 CAMBRIDGE RESEARCH PARK, WATERBEACH
CAMBRIDGE CB25 9TL , GB

Entity Type: 24

HORIZON DISCOVERY LIMITED (24 trademarks)

8100 CAMBRIDGE RESEARCH PARK
WATERBEACH, CAMBRIDGE CB259TL , GB

Entity Type: 99

Legal Representation

Attorney of Record

Kevin Oliver

152 trademarks filed View all →

Correspondence Address

Kevin Oliver Revvity, Inc.

940 Winter Street

Waltham, MA 02451

United States

Trademark Details

Filing Date

April 29, 2024

Registration Date

January 28, 2025

First Use Anywhere

June 8, 2015

First Use in Commerce

June 8, 2015

Published for Opposition

December 10, 2024

Goods & Services

Custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies

Biochemical preparations for scientific purposes; Biological preparations for use in industry and science; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use

Biological cloning services; Biological research laboratory services; Consulting services in the field of biotechnology; Gene therapy research; Medical and scientific research in the field of pharmaceuticals, medicine, biologics, biotherapeutics; Research and development in the field of biotechnology; Research and development services relating to vaccines; Research in the field of cell engineering technology; Research in the field of gene editing technology; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific laboratory services in the field of genomics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Biological engineering; Cell line engineering; Bioproduction cell line engineering